{
  "retracted": false,
  "timestamp": 1523923200000,
  "updates": [
    {
      "timestamp": 1581642617646,
      "identifier": {
        "doi": "10.1212/wnl.0000000000004908"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000004313"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy"
}
